⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

FORTIS - Fundamental Analysis: Financial Health & Valuation

Back to List

Rating: 2.8

Last Updated Time : 25 May 26, 12:02 am

Fundamental Rating: 2.8

Stock Code FORTIS Market Cap 72,631 Cr. Current Price 962 ₹ High / Low 1,105 ₹
Stock P/E 417 Book Value 122 ₹ Dividend Yield 0.10 % ROCE 3.27 %
ROE 1.41 % Face Value 10.0 ₹ DMA 50 918 ₹ DMA 200 880 ₹
Chg in FII Hold -1.86 % Chg in DII Hold 2.02 % PAT Qtr 24.7 Cr. PAT Prev Qtr 105 Cr.
RSI 58.3 MACD 19.9 Volume 12,96,325 Avg Vol 1Wk 11,75,621
Low price 699 ₹ High price 1,105 ₹ PEG Ratio 2.65 Debt to equity 0.22
52w Index 64.8 % Qtr Profit Var -30.0 % EPS 2.16 ₹ Industry PE 48.6

📊 Financials: FORTIS shows weak fundamentals currently. Quarterly PAT dropped sharply to 24.7 Cr from 105 Cr, reflecting margin pressure. ROCE at 3.27% and ROE at 1.41% are very low, indicating poor efficiency. EPS is only 2.16 ₹, highlighting limited profitability. Debt-to-equity at 0.22 is manageable, but cash flows remain under strain.

💰 Valuation: The stock trades at a P/E of 417, massively above the industry average of 48.6, making it extremely overvalued. Book value is 122 ₹, with current price at 962 ₹, implying a steep P/B ratio of ~7.9. PEG ratio of 2.65 further indicates stretched valuation relative to growth. Intrinsic value appears far below current levels, suggesting caution.

🏥 Business Model & Health: FORTIS operates in healthcare and hospital services, with strong brand recognition and established presence. Competitive advantage lies in scale, patient trust, and diversified medical offerings. However, profitability challenges and inflated valuations weaken overall health.

📉 Entry Zone: RSI at 58.3 indicates mildly overbought levels. Support is near 880 ₹, resistance at 1,105 ₹. Entry should be cautious, ideally closer to 880–900 ₹ if valuations normalize. Long-term holding is risky unless profitability stabilizes and margins improve.

Positive

  • 🏥 [Market Presence](ca://s?q=FORTIS_market_presence): Established brand in healthcare and hospital services.

  • 📈 [Institutional Support](ca://s?q=FORTIS_institutional_support): DII holdings increased by 2.02%.

  • 💹 [Sector Demand](ca://s?q=FORTIS_sector_demand): Healthcare demand remains strong in India.

Limitation

  • 📉 [Profit Decline](ca://s?q=FORTIS_profit_decline): PAT fell sharply from 105 Cr to 24.7 Cr.

  • ⚠️ [Valuation](ca://s?q=FORTIS_valuation): P/E of 417 is far above industry average.

  • 📊 [Weak Returns](ca://s?q=FORTIS_return_metrics): ROCE (3.27%) and ROE (1.41%) are very low.

Company Negative News

  • 📉 [Quarterly Loss Pressure](ca://s?q=FORTIS_quarterly_loss): PAT dropped significantly compared to previous quarter.

  • 📊 [FII Outflow](ca://s?q=FORTIS_FII_outflow): Foreign investors reduced holdings by -1.86%.

Company Positive News

  • 📈 [DII Support](ca://s?q=FORTIS_DII_support): Domestic institutions increased holdings by 2.02%.

Industry

  • 🏥 [Healthcare Growth](ca://s?q=Indian_healthcare_growth): Sector expanding with rising demand for medical services.

  • 📊 [Industry PE](ca://s?q=Healthcare_industry_PE): Sector average P/E is 48.6, far below FORTIS’s valuation.

Conclusion

⚠️ FORTIS currently reflects weak fundamentals, declining profitability, and extreme overvaluation. While it has strong brand presence and sector demand, financial health is fragile. Entry should be cautious near 880–900 ₹, and long-term holding is not advisable unless profitability stabilizes and valuations normalize.

Back to List
Technical Analysis
Fundamental Analysis

NIFTY 50 - Fundamental Stock Watchlist

NEXT 50 - Fundamental Stock Watchlist

MIDCAP - Fundamental Stock Watchlist

SMALLCAP - Fundamental Stock Watchlist